You are here: Knowledge Bank Press Releases

Press Releases

Press Releases is unique and effective promotional tool offered from aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

To add free press releases please click here.

Orion Pharma Animal Health and Vetoquinol Enter Distribution Collaboration from 1 January 2015

E-mail Print PDF

Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion's sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor and Domosedan and Antisedan.

Patheon Adds New Filling Technology to Milton Park Facility

E-mail Print PDF

Patheon has added a new filling technology that significantly reduces the time needed for formulation development and stability testing at its facility in Milton Park, UK.

The Xcelodose 600 S Automated Encapsulator supports early phase development for oral dose products.

Patheon Development and Manufacturing Presentation at Global Summit

E-mail Print PDF

An expert from Patheon will highlight the company's strategy for delivering exceptional customer experience through its integrated offerings at the Seventh Annual Global Biomanufacturing Summit.

Lonza Announces Agreement for the Supply of TiGenix's eASC Product Cx601

E-mail Print PDF

Lonza has announced an agreement for the supply of TiGenix's eASC product, Cx601.

Under the agreement, Lonza will manufacture material for the Phase III trial of Cx601 in the US at Lonza's cell therapy production facility in Walkersville, Maryland.

Boehringer Ingelheim Renews Global Technology Collaboration Agreement with VTU Technology

E-mail Print PDF

Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement. VTU Technology, currently offering a very broad and versatile technology platform available for Pichia pastoris protein production, will be responsible for carrying out the joint development program in VTU´s facilities in close collaboration between researchers from both companies. Boehringer Ingelheim has decided to prolong their ongoing technology agreement with VTU to further strengthen Pichia´s position as a highly attractive and competitive host for the production of biopharmaceuticals.

TxCell reports revenues for 2014 and updates on upcoming milestones

E-mail Print PDF

TxCell, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today reports its revenues[1] as of December 31, 2014 and updates on forthcoming milestones.

ELC GROUP to present at “Regulatory & Legal Affairs in Russia 2015” Conference

E-mail Print PDF

Dr. Parvinder Punia, Senior regulatory expert will present “European experience of harmonising the pharmaceutical market” at Moscow conference on February 10th 2015

Cambridge, UK, 2nd February 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs, today announces that its Senior Regulatory Affairs Manager Dr Parvinder Punia will be an invited speaker at the 3rd Annual Regulatory & Legal Affairs in Russia conference being held at the Marriott Grand Hotel in Moscow from February 10th – 12th 2015.


E-mail Print PDF

Cosmofarma Exhibition 2015, the leading event for the pharmacy world organized by Bologna Fiere and held in Bologna from 17 to 19 April, offers companies the most functional business opportunities with major national and international distributors. To encourage networking between companies and buyers, this year special initiatives designed specifically for the business needs of each company will be organized.

Pharma relies on education for patients

E-mail Print PDF
User Rating: / 1

80% of the finalists for the ‘Most Valuable Patient Initiative’ Categoryof the 2015 eyeforpharma Philadelphia Awards are focussing on education as a means of engaging with andimproving the lives of patients.

Dramatic shifts in pharma drive patient needs to trump all – including C-Suite authority

E-mail Print PDF
User Rating: / 1

eyeforpharma, London (January, 19, 2015): According to LEO Pharma, Ipsen and Grünenthaldriving patient-centric leadership has become priority as the patient voice shapes the future for the pharmaceutical industry.

Page 1 of 67

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »